MECANISME D'ACTIVATION DU PREMIER COMPLEXE DU SYSTEME COMPLEMENTAIRE C1.COLOMB M.1977; DGRST-7671194; FR.; DA. 1977; PP. (18P.); ABS. ANGL.; BIBL. 3 P. 1/2; (RAPP. FINAL ACTION COMPLEMENTAIRE COORDONNEE: INTERACTIONS MOL. BIOL.)Report

ASSEMBLY OF THE CYTOLYTIC ALTERNATIVE PATHWAY OF COMPLEMENT FROM 11 ISOLATED PLASMA PROTEINSSCHREIBER RD; MUELLER EBERHARD HJ.1978; J. EXPER. MED.; USA; DA. 1978; VOL. 148; NO 6; PP. 1722-1727; BIBL. 26 REF.Article

RATE PROCESSES IN THE FINAL STAGE OF COMPLEMENT HEMOLYSIS.LI CKN; LEVINE RP.1977; IMMUNOCHEMISTRY; G.B.; DA. 1977; VOL. 14; NO 6; PP. 421-428; BIBL. 18 REF.Article

DETERMINATION OF THE NUMBER OF LYTIC SITES IN BICONCAVE AND SPHEROID ERYTHROCYTE GHOSTS AFTER COMPLEMENT LYSISBAUER J; PODACK ER; VALET G et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 122; NO 5; PP. 2032-2036; BIBL. 21 REF.Article

1,10 PHENANTHROLINE MEDIATED HEMOLYSIS-EVIDENCE THAT 1,10 PHENANTHROLINE DOES NOT SUBSTITUTE SPECIFICALLY FOR C9BOYLE MDP; LANGONE JJ; BORSOS T et al.1979; MOL. IMMUNOL.; GBR; DA. 1979; VOL. 16; NO 5; PP. 307-312; BIBL. 20 REF.Article

A NEW ACTIVITY OF COMPLEMENT COMPONENT C3: CELL-BOUND C3B POTENTIATES LYSIS OF ERYTHROCYTES BY C5B,6 AND TERMINAL COMPONENTS.HAMMER CH; ABRAMOWITZ AS; MAYER MM et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 117; NO 3; PP. 830-834; BIBL. 16 REF.Article

RESTRICTION OF COMPLEMENT-MEDIATED MEMBRANE DAMAGE BY THE EIGHTH COMPONENT OF COMPLEMENT: A DUAL ROLE FOR C₈ IN THE COMPLEMENT ATTACK SEQUENCENEMEROW GR; YAMAMOTO KI; LINT TF et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 123; NO 3; PP. 1245-1252; BIBL. 27 REF.Article

KINETICS OF HAEMOLYSIS BY COMPLEMENT. I. CLASSIC KINETICS RE-EXAMINEDARQUEMBOURG PC; BURL BA.1978; ANN. IMMUNOL.; FRA; DA. 1978; VOL. 129; NO 6; PP. 819-830; ABS. FRE; BIBL. 9 REF.Article

STUDIES ON THE TERMINAL STAGES OF IMMUNE HEMOLYSIS. III. DISTINCTION BETWEEN THE INSERTION OF C9 AND THE FORMATION OF A TRANSMEMBRANE CHANNEL.BOYLE MDP; LANGONE JJ; BORSOS T et al.1978; J. IMMUNOL.; U.S.A.; DA. 1978; VOL. 120; NO 5; PP. 1721-1725; BIBL. 11 REF.Article

THE C5B-6 COMPLEX: FORMATION, ISOLATION, AND INHIBITION OF ITS ACTIVITY BY LIPOPROTEIN AND THE S-PROTEIN OF HUMAN SERUM.PODACK ER; KOLB WP; MUELLER EBERHARD HJ et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 120; NO 6; PP. 1841-1849; BIBL. 29 REF.Article

CHICKEN (GALLUS GALLUS) HEMOLYTIC COMPLEMENT: OPTIMAL CONDITIONS FOR ITS TITRATION.BARTA O; BARTA V.1975; IMMUNOL. COMMUNIC.; U.S.A.; DA. 1975; VOL. 4; NO 4; PP. 337-351; BIBL. 1 P. 1/2Article

STUDIES ON THE TERMINAL STAGES OF IMMUNE HEMOLYSIS. IV: EFFECT OF METAL SALTSBOYLE MDP; LANGONE JJ; BORSOS T et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 122; NO 4; PP. 1209-1213; BIBL. 24 REF.Article

COMPLEMENT LYSIS: EVIDENCE FOR AN AMPHIPHILIC NATURE OF THE TERMINAL MEMBRANE C5B-9 COMPLEX OF HUMAN COMPLEMENTBHAKDI S; BJERRUM OJ; BHAKDI LEHNEN B et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 6; PP. 2526-2532; BIBL. 34 REF.Article

A NEW FUNCTION OF THE ACTIVATED THIRD COMPONENT OF COMPLEMENT: BINDING TO C5, AN ESSENTIAL STEP FOR C5 ACTIVATION.VOGT W; SCHMIDT G; VON BUTTLAR B et al.1978; IMMUNOLOGY; G.B.; DA. 1978; VOL. 34; NO 1; PP. 29-40; BIBL. 16 REF.Article

RE-INCORPORATION OF THE TERMINAL C5B-9 COMPLEMENT COMPLEX INTO LIPID BILAYERS: FORMATION AND STABILITY OF RECONSTITUTED LIPOSOMESBHAKDI S; TRANUM JENSEN J.1980; IMMUNOLOGY; ISSN 0019-2805; GBR; DA. 1980; VOL. 41; NO 3; PP. 737-742; BIBL. 18 REF.Article

THE ACTION OF CHELATING AGENTS AND LOCAL ANESTHETICS ON THE TERMINAL STAGES OF IMMUNE HEMOLYSISESSER AF.1979; MOL. IMMUNOL.; GBR; DA. 1979; VOL. 16; NO 11; PP. 943-948; BIBL. 22 REF.Article

EFFECT OF CONCANAVALIN A ON THE FUNCTIONAL ACTIVITY OF HEMOLYTIC ANTIBODY.LANGONE JJ; BOYLE MDP; BORSOS T et al.1977; IMMUNOL. COMMUNIC.; U.S.A.; DA. 1977; VOL. 6; NO 3; PP. 283-296; BIBL. 12 REF.Article

LYTIC ACTIVITY OF C5-9 COMPLEXES FOR ERYTHROCYTES FROM THE SPECIES OTHER THAN SHEEP: C9 RATHER THAN C8-DEPENDENT VARIATION IN LYTIC ACTIVITY.YAMAMOTO K.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 4; PP. 1482-1485; BIBL. 19 REF.Article

MEMBRANE FLUIDITY CHANGE IN ERYTHROCYTE INDUCED BY COMPLEMENT SYSTEM.NAKAMURA M; OHNISHI S; INAI S et al.1976; BIOCHEMISTRY; U.S.A.; DA. 1976; VOL. 15; NO 22; PP. 4838-4843; BIBL. 21 REF.Article

MATHEMATICAL ANALYSIS OF THE REACTION OF EAC 1-8 WITH C9: IDENTIFICATION OF PARAMETERS DEFINING CONDITIONS FOR MOLECULAR TITRATIONDELISI C; BOYLE MDP; BORSOS T et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 5; PP. 2334-2338; BIBL. 20 REF.Article

THE C5B-6 COMPLEX: REACTION WITH C7, C8, C9.PODACK ER; BIESECKER G; KOLB WP et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 2; PP. 484-490; BIBL. 32 REF.Article

INFLUENCE OF AROMATIC COMPOUNDS ON THE INTERACTION OF ACTIVATED C4 WITH EAC1.BABA AS; TAMURA N.1977; IMMUNOLOGY; G.B.; DA. 1977; VOL. 32; NO 5; PP. 251-256; BIBL. 6 REF.Article

A CALCULATION OF THE NUMBER OF IGG MOLECULES REQUIRED PER CELL TO FIX COMPLEMENTPERELSON AS; WIEGEL FW.1979; J. THEOR. BIOL.; USA; DA. 1979; VOL. 79; NO 3; PP. 317-332; BIBL. 2 P.Article

MOLECULAR NATURE OF THE COMPLEMENT LESIONBHAKDI S; TRANUM JENSEN J.1978; PROC. NATION. ACAD. SCI.; USA; DA. 1978; VOL. 75; NO 11; PP. 5655-5659; BIBL. 39 REF.Article

FURTHER STUDIES ON THE BIOLOGICAL PROPERTIES OF GUINEA-PIG IGG1 ANTIBODIES. III. HAEMOLYTIC EFFICIENCY IN VITRO.VUAGNAT P.1977; IMMUNOLOGY; G.B.; DA. 1977; VOL. 32; NO 1; PP. 103-109; BIBL. 22 REF.Article